Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study
| Autor: | Alsamil, Ali M. a, b, Giezen, Thijs J. c, d, Egberts, Toine C. a, e, Leufkens, Hubert G. a, Gardarsdottir, Helga a, e, f, ∗ |
|---|---|
| Zdroj: | In Biologicals January 2021 69:30-37 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect